Table II.
Incidence of complications in the four age groups
| Age group [years] (n) | Surgical event, n (%)NS | Medical event, n (%)NS | Number of patients with endpoints, n (%)NS | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of events | Number of cases | Number of events | Number of cases | ||||||
| Bleeding | Early leak | Stenosis | Thrombo-embolism | Rhabdo-myolysis | Respiratory failure | ||||
| I: 18–33 (92) | 2 (2.2) | 0 | 0 | 2 (2.2) | 1 (1.1) | 4 (4.3) | 1 (1.1)* | 5 (5.4) | 7 (7.6) |
| II: 34–40 (86) | 3 (3.5) | 0 | 1 (1.2) | 4 (4.6) | 0 | 5 (5.8) | 1 (1.2)* | 5 (5.8) | 9 (10.5) |
| III: 41–49 (82) | 4 (4.9) | 0 | 1 (1.2) | 5 (6.1) | 1 (1.2)** | 2 (2.4)& | 0 | 3 (3.7) | 7 (8.5) |
| IV: ≥ 50 (85) | 8 (9.4) | 0 | 0 | 8 (9.4) | 0 | 5 (5.9) | 1 (1.2)* | 5 (5.9) | 13 (15.3) |
| Total (345) | 17 (4.9) | 0 | 2 (0.58) | 19 (5.5) | 2 (0.58) | 16 (4.6) | 3 (0.9) | 18 (5.2) | 36 (10.4) |
| Fisher’s exact test p-value | 0.168 | x | 0.484 | 0.205 | 0.735 | 0.708 | 1.000 | 0.917 | 0.380 |
*
Complication secondary to primary medical adverse event
&
1 case of rhabdomyolysis was associated with bleeding
**
fatal case
NS
no statistical significance.